STELARA® Phase 3 Extended UNIFI Study

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=VyKdlDqLn8k

Lead study investigator Dr. Bruce Sands, Icahn School of Medicine, Mt. Sinai, New York discusses Janssen's announcement of their new two-year data from the long-term extension of the Phase 3 UNIFI study of STELARA® (ustekinumab) that demonstrated long term efficacy and safety in adult patients with moderate to severe ulcerative colitis. This was presented as late-breaking data at the 27th United European Gastroenterology Week (UEGW) congress. • #STELARA #SevereUlcerativeColitis • Visit our website • www.healtprofessionalradio.com.au • Follow us on our social media channels • Facebook: / hprfm • Twitter: / healthproradio • Google+: https://plus.google.com/+HealthProfes... • Pinterest: / healthprora. . • Linkedin: / heal. . • Instagram: / healthprofe. . • Subscribe to our podcast channels • Soundcloud: / healthprofessi. . • Itunes: https://itunes.apple.com/nz/podcast/h... • Support us on Patreon • / hpr

#############################

New on site